Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
Moodys
Johnson and Johnson
Express Scripts
Boehringer Ingelheim

Last Updated: August 11, 2022

Investigational Drug Information for Apabetalone


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the drug development status for Apabetalone?

Apabetalone is an investigational drug.

There have been 8 clinical trials for Apabetalone. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2015.

The most common disease conditions in clinical trials are Hypertension, Cardiovascular Diseases, and Familial Primary Pulmonary Hypertension. The leading clinical trial sponsors are Resverlogix Corp, ICON plc, and Medidata Solutions.

There are thirty-seven US patents protecting this investigational drug and three hundred and fifty-four international patents.

Recent Clinical Trials for Apabetalone
TitleSponsorPhase
Apabetalone for Pulmonary Arterial HypertensionCanadian Institutes of Health Research (CIHR)Phase 2
Apabetalone for Pulmonary Arterial HypertensionResverlogix CorpPhase 2
Apabetalone for Pulmonary Arterial HypertensionInstitut universitaire de cardiologie et de pneumologie de Qu├ębec, University LavalPhase 2

See all Apabetalone clinical trials

Clinical Trial Summary for Apabetalone

Top disease conditions for Apabetalone
Top clinical trial sponsors for Apabetalone

See all Apabetalone clinical trials

US Patents for Apabetalone

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Apabetalone See Plans and Pricing Pharmaceutical compositions for substituted quinazolinones Resverlogix Corp. (Calgary, Alberta, CA) See Plans and Pricing
Apabetalone See Plans and Pricing Compositions and therapeutic methods for the treatment of complement-associated diseases Resverlogix Corp. (Calgary, Alberta, CA) See Plans and Pricing
Apabetalone See Plans and Pricing Anti-inflammatory agents Resverlogix Corp. (Calgary, Alberta, CA) See Plans and Pricing
Apabetalone See Plans and Pricing Controlled release dosage form TRIASTEK, INC. (Nanjing, CN) See Plans and Pricing
Apabetalone See Plans and Pricing Chemokine receptor modulators and uses thereof FLX Bio, Inc. (South San Francisco, CA) See Plans and Pricing
Apabetalone See Plans and Pricing Therapy for promoting cell growth MOLEAC PTE. LTD. (Singapore, SG) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Apabetalone

Drugname Country Document Number Estimated Expiration Related US Patent
Apabetalone Australia AU2012330885 2031-11-01 See Plans and Pricing
Apabetalone Canada CA2851996 2031-11-01 See Plans and Pricing
Apabetalone China CN103945848 2031-11-01 See Plans and Pricing
Apabetalone Denmark DK2773354 2031-11-01 See Plans and Pricing
Apabetalone European Patent Office EP2773354 2031-11-01 See Plans and Pricing
Apabetalone Spain ES2745471 2031-11-01 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
Moodys
Johnson and Johnson
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.